community download

Re-assessing orphan drugs after 4 years of CED

At Pharma Pricing & Market Access Europe 2013, Martin van der Graaff, CVZ gave a presentation entitled "Re-assessing orphan drugs after 4 years of CED"
 

Download the presentation and learn:

  • Problems with Pompe and Fabry re-evaluation after 4 years CED
  • "Outcomes" research
  • Reassessment woes
  • Reimbursement arrangements in some other countries
  • Future challenges

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (1,445Kb in size)